SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity

Journal of Investigative Dermatology

Volumn 134, Issue 8, 2014, Pages 2212-2220

  Graf, Saskia A ^a   Busch, Christian ^b   Bosserhoff, Anja Katrin ^c   Besch, Robert ^a   Berking, Carola ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX10;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHICK EMBRYO; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MELANOMA CELL LINE; MELANOMA INHIBITORY ACTIVITY GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE;

APOPTOSIS; CELL LINE, TUMOR; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; SOXE TRANSCRIPTION FACTORS;

EID: 84904460531     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.128     Document Type: Article

References (37)

1. Agnarsdó ttir M, Sooman L, Bolander A et al. (2010) SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Res 20, 468-78
2. Bakos RM, Maier T, Besch R et al. (2010) Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma. Exp Dermatol 19:e89-94
3. Berking C, Takemoto R, Satyamoorthy K et al. (2001) Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 158:943-53
4. Besch R, Poeck H, Hohenauer T et al. (2009) Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119:2399-411
5. Blesch A, Bosserhoff AK, Apfel R et al. (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 54: 5695-701
6. Bondurand N, Pingault V, Goerich DE et al. (2000) Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9:1907-17
7. Bosserhoff A-K, Kaufmann M, Kaluza B et al. (1997a) Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149-53
8. Bosserhoff AK, Hein R, Bogdahn U et al. (1996) Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA. J Biol Chem 271:490-5
9. Bosserhoff AK, Kondo S, Moser M et al. (1997b) Mouse CD-RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn Off Publ Am Assoc Anat 208:516-25
10. Busch C, Krochmann J, Drews U (2012) Human melanoma cells in the rhombencephalon of the chick embryo: A novel model for brain metastasis. Exp Dermatol 21:944-7
11. Busch C, Krochmann J, Drews U (2013) The chick embryo as an experimental system for melanoma cell invasion. PloS One 8:e53970
12. Civenni G, Walter A, Kobert N et al. (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71:3098-109
13. Cook AL, Smith AG, Smit DJ et al. (2005) Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp Cell Res 308:222-35
14. Cronin JC, Watkins-Chow DE, Incao AA et al. (2013) SOX10 ablation arrests the cell cycle, induces senescence and suppresses melanomagenesis. Cancer Res 73:5709-18
15. Cronin JC, Wunderlich J, Loftus SK et al. (2009) Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res 22:435-44
16. Dutton KA, Pauliny A, Lopes SS et al. (2001) Zebrafish colourless encodes sox10 and specifies non-ectmesenchymal neural crest fates. Development 128:4113-25
17. Flammiger A, Besch R, Cook AL et al. (2009) SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. J Invest Dermatol 129:945-53
18. Hamburger V, Hamilton H (1992) A series of normal stages in the development of the chick embryo. Dev Dyn 195:231-72
19. Harris ML, Baxter LL, Loftus SK et al. (2010) Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res 23:496-513
20. Herbarth B, Pingault V, Bondurand N et al. (1998) Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci USA 95:5161-5
21. Hohenauer T, Berking C, Schmidt A et al. (2013) The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival. EMBO Mol Med 5:919-34
22. Ludwig A, Rehberg S, Wegner M (2004) Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett 556:236-44
23. Mascarenhas JB, Littlejohn EL, Wolsky RJ et al. (2010) PAX3 and SOX10 activate MET receptor expression in melanoma. Pigment Cell Melanoma Res 23:225-37
24. Mohamed A, Gonzalez RS, Lawson D et al. (2012) SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol 21:506-10
25. Murisier F, Guichard S, Beermann F (2007) The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytesigment Cell Res Spons Eur Soc Pigment Cell Res Int Pigment Cell Soc 20:173-84
26. Nonaka D, Chiriboga L, Rubin BP (2008) Sox10: A pan-schwannian and melanocytic marker. Am J Surg Pathol 32:1291-8
27. Perez RP, Zhang P, Bosserhoff AK et al. (2000) Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens. Hum Pathol 31:1381-8
28. Poser I, Golob M, Buettner R et al. (2003) Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 23:2991-8
29. Poser I, Golob M, Weidner M et al. (2002) Down-regulation of COOHterminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res 62:5962-6
30. Potterf SB, Mollaaghababa R, Hou L et al. (2001) Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 237:245-57
31. Schmidt J, Riechers A, Bosserhoff A-K (2013) MIA-a new target protein for malignant melanoma therapy. Histol Histopathol 28:421-6
32. Schmid R, Schiffner S, Opolka A et al. (2010) Enhanced cartilage regeneration in MIA/CD-RAP deficient mice. Cell Death Dis 1:e97
33. Seong I, Min HJ, Lee J-H et al. (2012) Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes. PloS One 7:e31477
34. Shakhova O, Zingg D, Schaefer SM et al. (2012) Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol 14:882-90
35. Southard-Smith E, Kos L, Pavan WJ (1998) Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18: 60-4
36. Steunou A-L, Ducoux-Petit M, Lazar I et al. (2013) Identification of the hypoxia-inducible factor 2a nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Mol Cell Proteomics MCP 12:736-48
37. Xie WF, Zhang X, Sakano S et al. (1999) Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res Off J Am Soc Bone Miner Res 14:757-63